Perioperative care and cancer recurrence: Is there a connection?
|
摘要
Cancer is the second most common cause of death in the United States. Metastatic disease is a more important cause of cancer-related death relative to primary tumor progression. Surgical excision is the primary treatment for most malignant tumors. However, surgery itself can inhibit important host defenses and promote the development of metastases. An altered balance between the metastatic potential of the tumor and the anti-metastatic host defenses, including cellmediated immunity and natural killer cell function, is a plausible mechanism of increased cancer metastasis. This article reviews the increasingly recognized concept of anesthetic technique along with perioperative factors and their potential to affect long-term outcome after cancer surgery. The potential effect of intravenous anesthetics, volatile agents, local anesthetic drugs, opiates, and non-steroidal anti-inflammatory drugs are reviewed along with recent literature and ongoing clinical trials in this area. Regional anesthesia is increasingly emerging as a safer option with less cancer recurrence potential as compared to general anesthesia. Blood transfusion, pain, stress, use of beta-blockers, and hypothermia are other potentially important perioperative factors to consider.
Cancer is the second most common cause of death in the United States. Metastatic disease is a more important cause of cancer-related death relative to primary tumor progression. Surgical excision is the primary treatment for most malignant tumors. However, surgery itself can inhibit important host defenses and promote the development of metastases. An altered balance between the metastatic potential of the tumor and the anti-metastatic host defenses, including cellmediated immunity and natural killer cell function, is a plausible mechanism of increased cancer metastasis. This article reviews the increasingly recognized concept of anesthetic technique along with perioperative factors and their potential to affect long-term outcome after cancer surgery. The potential effect of intravenous anesthetics, volatile agents, local anesthetic drugs, opiates, and non-steroidal anti-inflammatory drugs are reviewed along with recent literature and ongoing clinical trials in this area. Regional anesthesia is increasingly emerging as a safer option with less cancer recurrence potential as compared to general anesthesia. Blood transfusion, pain, stress, use of beta-blockers, and hypothermia are other potentially important perioperative factors to consider.
Cancer is the second most common cause of death in the United States. Metastatic disease is a more important cause of cancer-related death relative to primary tumor progression. Surgical excision is the primary treatment for most malignant tumors. However, surgery itself can inhibit important host defenses and promote the development of metastases. An altered balance between the metastatic potential of the tumor and the anti-metastatic host defenses, including cellmediated immunity and natural killer cell function, is a plausible mechanism of increased cancer metastasis. This article reviews the increasingly recognized concept of anesthetic technique along with perioperative factors and their potential to affect long-term outcome after cancer surgery. The potential effect of intravenous anesthetics, volatile agents, local anesthetic drugs, opiates, and non-steroidal anti-inflammatory drugs are reviewed along with recent literature and ongoing clinical trials in this area. Regional anesthesia is increasingly emerging as a safer option with less cancer recurrence potential as compared to general anesthesia. Blood transfusion, pain, stress, use of beta-blockers, and hypothermia are other potentially important perioperative factors to consider.
引文
1 Hoyert D,Jiaquan X.Deaths:Preliminary Data for 2011.In:CDC,ed.Atlanta:CDC,2012:1-51
2 Siegel R,Naishadham D,Jemal A.Cancer statistics,2013.CA Cancer J Clin 2013;63:11-30[PMID:23335087 DOI:10.3322/caac.21166]
3 Weinberg R.The Biology of Cancer.In:Garland Science TFGL,editor The Biology of Cancer.New York,2007:587-653
4 Brewster AM,Hortobagyi GN,Broglio KR,Kau SW,SantaMaria CA,Arun B,Buzdar AU,Booser DJ,Valero V,Bondy M,Esteva FJ.Residual risk of breast cancer recurrence 5years after adjuvant therapy.J Natl Cancer Inst 2008;100:1179-1183[PMID:18695137 DOI:10.1093/jnci/djn233]
5 Coffey JC,Wang JH,Smith MJ,Bouchier-Hayes D,Cotter TG,Redmond HP.Excisional surgery for cancer cure:therapy at a cost.Lancet Oncol 2003;4:760-768[PMID:14662433]
6 Ceelen WP,Morris S,Paraskeva P,Pattyn P.Surgical trauma,minimal residual disease and locoregional cancer recurrence.Cancer Treat Res 2007;134:51-69[PMID:17633047]
7 Tai LH,de Souza CT,Bélanger S,Ly L,Alkayyal AA,Zhang J,Rintoul JL,Ananth AA,Lam T,Breitbach CJ,Falls TJ,Kirn DH,Bell JC,Makrigiannis AP,Auer RA.Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells.Cancer Res 2013;73:97-107[PMID:23090117 DOI:10.1158/0008-5472.CAN-12-1993]
8 Fidler IJ.The pathogenesis of cancer metastasis:the‘seed and soil’hypothesis revisited.Nat Rev Cancer 2003;3:453-458[PMID:12778135 DOI:10.1038/nrc1098]
9 Langley RR,Fidler IJ.Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis.Endocr Rev 2007;28:297-321[PMID:17409287 DOI:10.1210/er.2006-0027]
10 Shakhar G,Ben-Eliyahu S.Potential prophylactic measures against postoperative immunosuppression:could they reduce recurrence rates in oncological patients?Ann Surg Oncol 2003;10:972-992[PMID:14527919]
11 Brittenden J,Heys SD,Ross J,Eremin O.Natural killer cells and cancer.Cancer 1996;77:1226-1243[PMID:8608497]
12 Uchida A,Kariya Y,Okamoto N,Sugie K,Fujimoto T,Yagita M.Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients.J Natl Cancer Inst 1990;82:1697-1701[PMID:2231757]
13 Campbell KS,Hasegawa J.Natural killer cell biology:an update and future directions.J Allergy Clin Immunol 2013;132 :536-544[PMID:23906377 DOI:10.1016/j.jaci.2013.07.006]
14 Orange JS.Human natural killer cell deficiencies.Curr Opin Allergy Clin Immunol 2006;6:399-409[PMID:17088643 DOI:10 .1097/ACI.0b013e3280106b65]
15 Liljefors M,Nilsson B,Hjelm Skog AL,Ragnhammar P,Mellstedt H,Fr?din JE.Natural killer(NK)cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.Int J Cancer2003;105:717-723[PMID:12740924 DOI:10.1002/ijc.11139]
16 Kondo E,Koda K,Takiguchi N,Oda K,Seike K,Ishizuka M,Miyazaki M.Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer.Dig Surg 2003;20:445-451[PMID:12900537DOI:10.1159/000072714]
17 Andersen BL,Farrar WB,Golden-Kreutz D,Kutz LA,MacCallum R,Courtney ME,Glaser R.Stress and immune responses after surgical treatment for regional breast cancer.J Natl Cancer Inst 1998;90:30-36[PMID:9428780]
18 Ben-Eliyahu S,Page GG,Yirmiya R,Shakhar G.Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity.Int J Cancer 1999;80:880-888[PMID:10074922]
19 Penn I.The effect of immunosuppression on pre-existing cancers.Transplantation 1993;55:742-747[PMID:8475546]
20 Yeager MP,Rosenkranz KM.Cancer recurrence after surgery:a role for regional anesthesia?Reg Anesth Pain Med2010;35:483-484[PMID:20975458 DOI:10.1097/AAP.0b013e3181fa11a9]
21 Liu SS,Wu CL.The effect of analgesic technique on postoperative patient-reported outcomes including analgesia:a systematic review.Anesth Analg 2007;105:789-808[PMID:17717242 DOI:10.1213/01.ane.0000278089.16848.1e]
22 Tian T,Olson S,Whitacre JM,Harding A.The origins of cancer robustness and evolvability.Integr Biol(Camb)2011;3:17 -30[PMID:20944865 DOI:10.1039/c0ib00046a]
23 Chen DS,Mellman I.Oncology meets immunology:the cancer-immunity cycle.Immunity 2013;39:1-10[PMID:23890059DOI:10.1016/j.immuni.2013.07.012]
24 Boon T,Cerottini JC,Van den Eynde B,van der Bruggen P,Van Pel A.Tumor antigens recognized by T lymphocytes.Annu Rev Immunol 1994;12:337-365[PMID:8011285 DOI:10 .1146/annurev.iy.12.040194.002005]
25 Kaplan DH,Shankaran V,Dighe AS,Stockert E,Aguet M,Old LJ,Schreiber RD.Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.Proc Natl Acad Sci USA 1998;95:7556-7561[PMID:9636188]
26 Shankaran V,Ikeda H,Bruce AT,White JM,Swanson PE,Old LJ,Schreiber RD.IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.Nature 2001;410:1107-1111[PMID:11323675 DOI:10 .1038/35074122]
27 Vivier E,Raulet DH,Moretta A,Caligiuri MA,Zitvogel L,Lanier LL,Yokoyama WM,Ugolini S.Innate or adaptive immunity?The example of natural killer cells.Science 2011;331:44 -49[PMID:21212348 DOI:10.1126/science.1198687]
28 Vivier E,Ugolini S,Blaise D,Chabannon C,Brossay L.Targeting natural killer cells and natural killer T cells in cancer.Nat Rev Immunol 2012;12:239-252[PMID:22437937 DOI:10 .1038/nri3174]
29 Dunn GP,Old LJ,Schreiber RD.The immunobiology of cancer immunosurveillance and immunoediting.Immunity2004;21:137-148[PMID:15308095 DOI:10.1016/j.immuni.2004.07.017]
30 Baum M,Demicheli R,Hrushesky W,Retsky M.Does surgery unfavourably perturb the“natural history”of early breast cancer by accelerating the appearance of distant metastases?Eur J Cancer 2005;41:508-515[PMID:15737554DOI:10.1016/j.ejca.2004.09.031]
31 Ben-Eliyahu S.The promotion of tumor metastasis by surgery and stress:immunological basis and implications for psychoneuroimmunology.Brain Behav Immun 2003;17 Suppl1 :S27-S36[PMID:12615183]
32 Weitz J,Herfarth C.Surgical strategies and minimal residual disease detection.Semin Surg Oncol 2001;20:329-333[PMID:11747275]
33 Oefelein MG,Kaul K,Herz B,Blum MD,Holland JM,Keeler TC,Cook WA,Ignatoff JM.Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy.J Urol 1996;155:238 -242[PMID:7490843]
34 Yamaguchi K,Takagi Y,Aoki S,Futamura M,Saji S.Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.Ann Surg 2000;232:58-65[PMID:10862196]
35 Kim SH,Choe C,Shin YS,Jeon MJ,Choi SJ,Lee J,Bae GY,Cha HJ,Kim J.Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in coculture.Anticancer Res 2013;33:2001-2009[PMID:23645749]
36 Goldfarb Y,Ben-Eliyahu S.Surgery as a risk factor for breast cancer recurrence and metastasis:mediating mechanisms and clinical prophylactic approaches.Breast Dis 2006;26:99 -114[PMID:17473369]
37 Ekblad L,Lindgren G,Persson E,Kjellén E,Wennerberg J.Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors-a central role for STAT3.BMC Cancer2013;13:33[PMID:23351302 DOI:10.1186/1471-2407-13-33]
38 Szarvas T,J?ger T,Laszlo V,Kramer G,Klingler HC,vom Dorp F,Romics I,Ergün S,Rübben H.Circulating angiostatin,b FGF,and Tie2/TEK levels and their prognostic impact in bladder cancer.Urology 2012;80:737.e13-737.e18[PMID:22607948 DOI:10.1016/j.urology.2012.03.023]
39 Fukuda H,Mochizuki S,Abe H,Okano HJ,Hara-Miyauchi C,Okano H,Yamaguchi N,Nakayama M,D’Armiento J,Okada Y.Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.Br J Cancer 2011;105:1615-1624[PMID:22015555DOI:10.1038/bjc.2011.431]
40 Reader J,Holt D,Fulton A.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Cancer Metastasis Rev2011;30:449-463[PMID:22002714 DOI:10.1007/s10555-011-9303-2]
41 Howe LR.Inflammation and breast cancer.Cyclooxygenase/prostaglandin signaling and breast cancer.Breast Cancer Res 2007;9:210[PMID:17640394 DOI:10.1186/bcr1678]
42 Condeelis J,Pollard JW.Macrophages:obligate partners for tumor cell migration,invasion,and metastasis.Cell 2006;124 :263-266[PMID:16439202 DOI:10.1016/j.cell.2006.01.007]
43 Wang L,Chen W,Xie X,He Y,Bai X.Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.Exp Oncol 2008;30:42 -51[PMID:18438340]
44 Sloan EK,Priceman SJ,Cox BF,Yu S,Pimentel MA,Tangkanangnukul V,Arevalo JM,Morizono K,Karanikolas BD,Wu L,Sood AK,Cole SW.The sympathetic nervous system induces a metastatic switch in primary breast cancer.Cancer Res 2010;70:7042-7052[PMID:20823155 DOI:10 .1158/0008-5472.CAN-10-0522]
45 Palm D,Lang K,Niggemann B,Drell TL,Masur K,Zaenker KS,Entschladen F.The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.Int J Cancer 2006;118 :2744-2749[PMID:16381019 DOI:10.1002/ijc.21723]
46 Cole SW,Sood AK.Molecular pathways:beta-adrenergic signaling in cancer.Clin Cancer Res 2012;18:1201-1206[PMID:22186256 DOI:10.1158/1078-0432.CCR-11-0641]
47 Cole SW,Arevalo JM,Takahashi R,Sloan EK,Lutgendorf SK,Sood AK,Sheridan JF,Seeman TE.Computational identification of gene-social environment interaction at the human IL6 locus.Proc Natl Acad Sci USA 2010;107:5681-5686[PMID:20176930 DOI:10.1073/pnas.0911515107]
48 Shahzad MM,Arevalo JM,Armaiz-Pena GN,Lu C,Stone RL,Moreno-Smith M,Nishimura M,Lee JW,Jennings NB,Bottsford-Miller J,Vivas-Mejia P,Lutgendorf SK,LopezBerestein G,Bar-Eli M,Cole SW,Sood AK.Stress effects on FosB-and interleukin-8(IL8)-driven ovarian cancer growth and metastasis.J Biol Chem 2010;285:35462-35470[PMID:20826776 DOI:10.1074/jbc.M110.109579]
49 Sastry KS,Karpova Y,Prokopovich S,Smith AJ,Essau B,Gersappe A,Carson JP,Weber MJ,Register TC,Chen YQ,Penn RB,Kulik G.Epinephrine protects cancer cells from apoptosis via activation of cA MP-dependent protein kinase and BAD phosphorylation.J Biol Chem 2007;282:14094-14100[PMID:17353197 DOI:10.1074/jbc.M611370200]
50 Sood AK,Armaiz-Pena GN,Halder J,Nick AM,Stone RL,Hu W,Carroll AR,Spannuth WA,Deavers MT,Allen JK,Han LY,Kamat AA,Shahzad MM,Mc Intyre BW,DiazMontero CM,Jennings NB,Lin YG,Merritt WM,DeG eest K,Vivas-Mejia PE,Lopez-Berestein G,Schaller MD,Cole SW,Lutgendorf SK.Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.J Clin Invest 2010;120:1515-1523[PMID:20389021 DOI:10.1172/JCI40802]
51 Inbar S,Neeman E,Avraham R,Benish M,Rosenne E,BenEliyahu S.Do stress responses promote leukemia progression?An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.PLo S One 2011;6:e19246[PMID:21559428 DOI:10.1371/journal.pone.0019246]
52 Obeid EI,Conzen SD.The role of adrenergic signaling in breast cancer biology.Cancer Biomark 2013;13:161-169[PMID:23912488 DOI:10.3233/CBM-130347]
53 Landen CN,Lin YG,Armaiz Pena GN,Das PD,Arevalo JM,Kamat AA,Han LY,Jennings NB,Spannuth WA,Thaker PH,Lutgendorf SK,Savary CA,Sanguino AM,Lopez-Berestein G,Cole SW,Sood AK.Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.Cancer Res 2007;67:10389-10396[PMID:17974982DOI:10.1158/0008-5472.CAN-07-0858]
54 Sood AK,Bhatty R,Kamat AA,Landen CN,Han L,Thaker PH,Li Y,Gershenson DM,Lutgendorf S,Cole SW.Stress hormone-mediated invasion of ovarian cancer cells.Clin Cancer Res 2006;12:369-375[PMID:16428474 DOI:10 .1158/1078-0432.CCR-05-1698]
55 Cakir Y,Plummer HK,Tithof PK,Schuller HM.Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines.Int J Oncol 2002;21:153-157[PMID:12063562]
56 Li Q,Liang Z,Nakadai A,Kawada T.Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells,cytotoxic T lymphocytes,natural killer receptors and m RNA transcripts for granzymes and perforin.Stress 2005;8:107-116[PMID:16019602 DOI:10.1080/10253890500140972]
57 Sacerdote P,Manfredi B,Bianchi M,Panerai AE.Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat.Brain Behav Immun 1994;8:251-260[PMID:7865896 DOI:10.1006/brbi.1994.1023]
58 Shavit Y,Martin FC,Yirmiya R,Ben-Eliyahu S,Terman GW,Weiner H,Gale RP,Liebeskind JC.Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity.Brain Behav Immun 1987;1:318-328[PMID:3453207]
59 Bar-Yosef S,Melamed R,Page GG,Shakhar G,Shakhar K,Ben-Eliyahu S.Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats.Anesthesiology 2001;94:1066-1073[PMID:11465599]
60 Lewis JW,Shavit Y,Terman GW,Nelson LR,Gale RP,Liebeskind JC.Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth.Peptides 1983;4 :635-638[PMID:6686324]
61 Sharify A,Mahmoudi M,Izad MH,Hosseini MJ,Sharify M.Effect of acute pain on splenic NK cell activity,lymphocyte proliferation and cytokine production activities.Immunopharmacol Immunotoxicol 2007;29:465-476[PMID:18075858DOI:10.1080/08923970701619877]
62 Page GG.Acute pain and immune impairment.Pain Clin Updates 2005;13:1-4
63 Snyder GL,Greenberg S.Effect of anaesthetic technique and other perioperative factors on cancer recurrence.Br J Anaesth 2010;105:106-115[PMID:20627881 DOI:10.1093/bja/aeq164]
64 Lundy J,Lovett EJ,Hamilton S,Conran P.Halothane,surgery,immunosuppression and artificial pulmonary metastases.Cancer 1978;41:827-830[PMID:638970]
65 Shapiro J,Jersky J,Katzav S,Feldman M,Segal S.Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors.J Clin Invest 1981;68:678-685[PMID:7276167]
66 Urner M,Limbach LK,Herrmann IK,Müller-Edenborn B,Roth-Z’Graggen B,Schlicker A,Reyes L,Booy C,Hasler M,Stark WJ,Beck-Schimmer B.Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury.Am J Respir Cell Mol Biol 2011;45:617-624[PMID:21239603 DOI:10.1165/rcmb.2010-0451OC]
67 Kurosawa S,Kato M.Anesthetics,immune cells,and immune responses.J Anesth 2008;22:263-277[PMID:18685933DOI:10.1007/s00540-008-0626-2]
68 Saad MM,Eom W,Hu G,Kim SJ,Crystal GJ.Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils.Can J Anaesth 2010;57:50-57[PMID:19882198 DOI:10.1007/s12630-009-9205-8]
69 Biao Z,Zhanggang X,Hao J,Changhong M,Jing C.The in vitro effect of desflurane preconditioning on endothelial adhesion molecules and m RNA expression.Anesth Analg2005;100:1007-1013[PMID:15781515 DOI:10.1213/01.ANE.0000146432.39090.D4]
70 Hu G,Vinten-Johansen J,Salem MR,Zhao ZQ,Crystal GJ.Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation:lack of a role for adenosine triphosphate-sensitive potassium channels.Anesth Analg 2002;94:849 -56,table of contents[PMID:11916783]
71 Drenger B,Gozal Y,Ginosar Y,Tochner Z,Chevion M.Halothane modifies oxygen free radical activity on the voltagesensitive calcium channels in canine myocardial membranes.Ann Card Anaesth 1999;2:16-21[PMID:17846486]
72 Benzonana LL,Perry NJ,Watts HR,Yang B,Perry IA,Coombes C,Takata M,Ma D.Isoflurane,a commonly used volatile anesthetic,enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.Anesthesiology 2013;119:593-605[PMID:23774231 DOI:10.1097/ALN.0b013e31829e47fd]
73 Hyv?rinen J,Hassinen IE,Sormunen R,M?ki JM,Kivirikko KI,Koivunen P,Myllyharju J.Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.J Biol Chem2010;285:13646-13657[PMID:20185832 DOI:10.1074/jbc.M109.084855]
74 Bautista L,Castro MJ,López-Barneo J,Castellano A.Hypoxia inducible factor-2alpha stabilization and maxi-K+channel beta1-subunit gene repression by hypoxia in cardiac myocytes:role in preconditioning.Circ Res 2009;104:1364-1372[PMID:19461047 DOI:10.1161/CIRCRESAHA.108.190645]
75 Prabhakar NR,Semenza GL.Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.Physiol Rev 2012;92:967-1003[PMID:22811423 DOI:10.1152/physrev.00030.2011]
76 Ma D,Lim T,Xu J,Tang H,Wan Y,Zhao H,Hossain M,Maxwell PH,Maze M.Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.J Am Soc Nephrol 2009;20:713-720[PMID:19144758DOI:10.1681/ASN.2008070712]
77 Zitta K,Meybohm P,Bein B,Ohnesorge H,Steinfath M,Scholz J,Albrecht M.Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning:findings from a human,in-vitro hypoxia model.Eur J Pharmacol 2010;645:39-46[PMID:20655305 DOI:10.1016/j.ejphar.2010.07.017]
78 Lang XE,Wang X,Jin JH.Mechanisms of cardioprotection by isoflurane against I/R injury.Front Biosci(Landmark Ed)2013;18:387-393[PMID:23276931]
79 Zhang L,Huang H,Cheng J,Liu J,Zhao H,Vizcaychipi MP,Ma D.Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice.Life Sci 2011;88:1102-1107[PMID:21565202 DOI:10.1016/j.lfs.2011.04.004]
80 Müller-Edenborn B,Roth-Z’graggen B,Bartnicka K,Borgeat A,Hoos A,Borsig L,Beck-Schimmer B.Volatile anesthetics reduce invasion of colorectal cancer cells through downregulation of matrix metalloproteinase-9.Anesthesiology 2012;117 :293-301[PMID:22739763 DOI:10.1097/ALN.0b013e3182605df1]
81 Yuki K,Astrof NS,Bracken C,Soriano SG,Shimaoka M.Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1.Anesthesiology 2010;113:600 -609[PMID:20693879 DOI:10.1097/ALN.0b013e3181e89a77]
82 Yuki K,Astrof NS,Bracken C,Yoo R,Silkworth W,Soriano SG,Shimaoka M.The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity.FASEB J 2008;22:4109-4116[PMID:18708587 DOI:10.1096/fj.08-113324]
83 Loop T,Dovi-Akue D,Frick M,Roesslein M,Egger L,Humar M,Hoetzel A,Schmidt R,Borner C,Pahl HL,Geiger KK,Pannen BH.Volatile anesthetics induce caspase-dependent,mitochondria-mediated apoptosis in human T lymphocytes in vitro.Anesthesiology 2005;102:1147-1157[PMID:15915027]
84 Rem J,Brandt MR,Kehlet H.Prevention of postoperative lymphopenia and granulocytosis by epidural analgesia.Lancet 1980;1:283-284[PMID:6101739]
85 Vallejo R,Hord ED,Barna SA,Santiago-Palma J,Ahmed S.Perioperative immunosuppression in cancer patients.J Environ Pathol Toxicol Oncol 2003;22:139-146[PMID:14533877]
86 Woods GM,Griffiths DM.Reversible inhibition of natural killer cell activity by volatile anaesthetic agents in vitro.Br J Anaesth 1986;58:535-539[PMID:3457589]
87 Markovic SN,Knight PR,Murasko DM.Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane.Anesthesiology 1993;78:700 -706[PMID:8466070]
88 T?nnesen E,Brinkl?v MM,Christensen NJ,Olesen AS,Madsen T.Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response.Anesthesiology 1987;67:526 -533[PMID:3499099]
89 Markovic SN,Murasko DM.Anesthesia inhibits interferoninduced natural killer cell cytotoxicity via induction of CD8+suppressor cells.Cell Immunol 1993;151:474-480[PMID:8402951 DOI:10.1006/cimm.1993.1256]
90 Braz MG,Mazoti Má,Giacobino J,Braz LG,Golim Mde A,Ferrasi AC,de Carvalho LR,Braz JR,Salvadori DM.Genotoxicity,cytotoxicity and gene expression in patients undergoing elective surgery under isoflurane anaesthesia.Mutagenesis 2011;26:415-420[PMID:21257718 DOI:10.1093/mutage/geq109]
91 Musak L,Smerhovsky Z,Halasova E,Osina O,Letkova L,Vodickova L,Polakova V,Buchancova J,Hemminki K,Vodicka P.Chromosomal damage among medical staff occupationally exposed to volatile anesthetics,antineoplastic drugs,and formaldehyde.Scand J Work Environ Health 2013;39 :618-630[PMID:23525098 DOI:10.5271/sjweh.3358]
92 Heine J,Leuwer M,Scheinichen D,Arseniev L,Jaeger K,Piepenbrock S.Flow cytometry evaluation of the in vitro influence of four i.v.anaesthetics on respiratory burst of neutrophils.Br J Anaesth 1996;77:387-392[PMID:8949817]
93 Melamed R,Bar-Yosef S,Shakhar G,Shakhar K,Ben-Eliyahu S.Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine,thiopental,and halothane,but not by propofol:mediating mechanisms and prophylactic measures.Anesth Analg 2003;97:1331-1339[PMID:14570648]
94 Salo M,Pirttikangas CO,Pulkki K.Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro.Anaesthesia 1997;52:341-344[PMID:9135186]
95 Chen RM,Wu CH,Chang HC,Wu GJ,Lin YL,Sheu JR,Chen TL.Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis.Anesthesiology 2003;98:1178-1185[PMID:12717140]
96 Heller A,Heller S,Blecken S,Urbaschek R,Koch T.Effects of intravenous anesthetics on bacterial elimination in human blood in vitro.Acta Anaesthesiol Scand 1998;42:518-526[PMID:9605366]
97 Wu GJ,Tai YT,Chen TL,Lin LL,Ueng YF,Chen RM.Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity,thus reducing cellular ATP biosynthesis and migration of macrophages.Ann N Y Acad Sci 2005;1042:168-176[PMID:15965060 DOI:10.1196/annals.1338.019]
98 Hardwick M,Fertikh D,Culty M,Li H,Vidic B,Papadopoulos V.Peripheral-type benzodiazepine receptor(PBR)in human breast cancer:correlation of breast cancer cell aggressive phenotype with PBR expression,nuclear localization,and PBR-mediated cell proliferation and nuclear transport of cholesterol.Cancer Res 1999;59:831-842[PMID:10029072]
99 Garib V,Niggemann B,Z?nker KS,Brandt L,Kubens BS.Influence of non-volatile anesthetics on the migration behavior of the human breast cancer cell line MDA-MB-468.Acta Anaesthesiol Scand 2002;46:836-844[PMID:12139540]
100 Katzav S,Shapiro J,Segal S,Feldman M.General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity.Isr J Med Sci 1986;22:339-345[PMID:3744781]
101 Bentley MW,Stas JM,Johnson JM,Viet BC,Garrett N.Effects of preincisional ketamine treatment on natural killer cell activity and postoperative pain management after oral maxillofacial surgery.AANA J 2005;73:427-436[PMID:16355944]
102 Singleton PA,Moreno-Vinasco L,Sammani S,Wanderling SL,Moss J,Garcia JG.Attenuation of vascular permeability by methylnaltrexone:role of m OP-R and S1P3 transactivation.Am J Respir Cell Mol Biol 2007;37:222-231[PMID:17395891 DOI:10.1165/rcmb.2006-0327OC]
103 Singleton PA,Moss J.Effect of perioperative opioids on cancer recurrence:a hypothesis.Future Oncol 2010;6:1237-1242[PMID:20799870 DOI:10.2217/fon.10.99]
104 Carr DJ,Rogers TJ,Weber RJ.The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis.Proc Soc Exp Biol Med 1996;213:248-257[PMID:8985308]
105 Flores LR,Dretchen KL,Bayer BM.Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration.Eur J Pharmacol 1996;318:437 -446[PMID:9016936]
106 Freier DO,Fuchs BA.A mechanism of action for morphineinduced immunosuppression:corticosterone mediates morphine-induced suppression of natural killer cell activity.J Pharmacol Exp Ther 1994;270:1127-1133[PMID:7932161]
107 Bryant HU,Bernton EW,Kenner JR,Holaday JW.Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment.Endocrinology 1991;128:3253-3258[PMID:2036988]
108 Mellon RD,Bayer BM.Evidence for central opioid receptors in the immunomodulatory effects of morphine:review of potential mechanism(s)of action.J Neuroimmunol 1998;83:19 -28[PMID:9610669]
109 Shavit Y,Ben-Eliyahu S,Zeidel A,Beilin B.Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats.Dose and timing study.Neuroimmunomodulation2004;11:255-260[PMID:15249732 DOI:10.1159/000078444]
110 Li W,Tang HZ,Jiang YB,Xu MX.[Influence of different doses of fentanyl on T-lymphocyte subpopulations and natural killer cells of patients with esophageal tumor during preoperation and postoperation].Aizheng 2003;22:634-636[PMID:12948416]
111 Jaeger K,Scheinichen D,Heine J,AndréM,Bund M,Piepenbrock S,Leuwer M.Remifentanil,fentanyl,and alfentanil have no influence on the respiratory burst of human neutrophils in vitro.Acta Anaesthesiol Scand 1998;42:1110-1113[PMID:9809098]
112 Gaspani L,Bianchi M,Limiroli E,Panerai AE,Sacerdote P.The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats.J Neuroimmunol 2002;129:18-24[PMID:12161016]
113 Liu YM,Zhu SM,Wang KR,Feng ZY,Chen QL.Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain.Zhejiang Daxue Kexue Zazhi B 2008;9:895-902[PMID:18988309 DOI:10.1631/jzus.B0820039]
114 Sacerdote P,Bianchi M,Gaspani L,Manfredi B,Maucione A,Terno G,Ammatuna M,Panerai AE.The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients.Anesth Analg 2000;90:1411-1414[PMID:10825330]
115 McL aughlin PJ,Zagon IS.The opioid growth factor-opioid growth factor receptor axis:homeostatic regulator of cell proliferation and its implications for health and disease.Biochem Pharmacol 2012;84:746-755[PMID:22687282 DOI:10 .1016/j.bcp.2012.05.018]
116 Spirkoski J,Melo FR,Grujic M,Calounova G,Lundequist A,Wernersson S,Pejler G.Mast cell apoptosis induced by siramesine,a sigma-2 receptor agonist.Biochem Pharmacol 2012;84:1671-1680[PMID:23058984 DOI:10.1016/j.bcp.2012.09.028]
117 Stefano GB,Kream RM,Mantione KJ,Sheehan M,Cadet P,Zhu W,Bilfinger TV,Esch T.Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression:implications for cancer biology.Semin Cancer Biol2008;18:199-210[PMID:18203618 DOI:10.1016/j.semcancer.2007.12.003]
118 Cadet P,Rasmussen M,Zhu W,Tonnesen E,Mantione KJ,Stefano GB.Endogenous morphinergic signaling and tumor growth.Front Biosci 2004;9:3176-3186[PMID:15353348]
119 Tegeder I,Gr?sch S,Schmidtko A,H?ussler A,Schmidt H,Niederberger E,Scholich K,Geisslinger G.G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells:involvement of p53 phosphorylation.Cancer Res 2003;63:1846-1852[PMID:12702572]
120 Tsujikawa H,Shoda T,Mizota T,Fukuda K.Morphine induces DNA damage and P53 activation in CD3+T cells.Biochim Biophys Acta 2009;1790:793-799[PMID:19397953 DOI:10 .1016/j.bbagen.2009.04.011]
121 Yin D,Woodruff M,Zhang Y,Whaley S,Miao J,Ferslew K,Zhao J,Stuart C.Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappa B pathways.J Neuroimmunol 2006;174 :101-107[PMID:16529824 DOI:10.1016/j.jneuroim.2006.02.001]
122 Qin Y,Chen J,Li L,Liao CJ,Liang YB,Guan EJ,Xie YB.Exogenous morphine inhibits human gastric cancer MGC803 cell growth by cell cycle arrest and apoptosis induction.Asian Pac J Cancer Prev 2012;13:1377-1382[PMID:22799335]
123 Gach K,Wyrebska A,Fichna J,Janecka A.The role of morphine in regulation of cancer cell growth.Naunyn Schmiedebergs Arch Pharmacol 2011;384:221-230[PMID:21800094DOI:10.1007/s00210-011-0672-4]
124 Chen YL,Law PY,Loh HH.The other side of the opioid story:modulation of cell growth and survival signaling.Curr Med Chem 2008;15:772-778[PMID:18393846]
125 Yeager MP,Colacchio TA.Effect of morphine on growth of metastatic colon cancer in vivo.Arch Surg 1991;126:454-456[PMID:2009060]
126 Page GG,Ben-Eliyahu S,Yirmiya R,Liebeskind JC.Morphine attenuates surgery-induced enhancement of metastatic colonization in rats.Pain 1993;54:21-28[PMID:8378099]
127 Page GG,Ben-Eliyahu S,Liebeskind JC.The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine.Brain Behav Immun 1994;8:241-250[PMID:7865895]
128 Tarhini AA,Cherian J,Moschos SJ,Tawbi HA,Shuai Y,Gooding WE,Sander C,Kirkwood JM.Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.J Clin Oncol 2012;30:322-328[PMID:22184371 DOI:10.1200/JCO.2011.37.5394]
129 Van Gool AR,Van Ojik HH,Kruit WH,Mulder PG,Fekkes D,Bannink M,ScharpéS,Stoter G,Eggermont AM,Maes M,Verkerk R.Serum activity of prolyl endopeptidase,but not of dipeptidyl peptidase IV,is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients.J Interferon Cytokine Res 2004;24:411-415[PMID:15296652 DOI:10.1089/1079990041535629]
130 Van Gool AR,Verkerk R,Fekkes D,Sleijfer S,Bannink M,Kruit WH,van der Holt B,ScharpéS,Eggermont AM,Stoter G,Hengeveld MW.Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-alpha in patients with renal cell carcinoma.J Interferon Cytokine Res 2008;28:283-286[PMID:18547158 DOI:10 .1089/jir.2007.0058]
131 Hollmann MW,Gross A,Jelacin N,Durieux ME.Local anesthetic effects on priming and activation of human neutrophils.Anesthesiology 2001;95:113-122[PMID:11465548]
132 Johnson SM,Saint John BE,Dine AP.Local anesthetics as antimicrobial agents:a review.Surg Infect(Larchmt)2008;9:205 -213[PMID:18426354 DOI:10.1089/sur.2007.036]
133 Di Padova M,Barbieri R,Fanciulli M,Arcuri E,Floridi A.Effect of local anesthetic ropivacaine on the energy metabolism of Ehrlich ascites tumor cells.Oncol Res 1998;10:491-498[PMID:10338152]
134 Mammoto T,Higashiyama S,Mukai M,Mammoto A,Ayaki M,Mashimo T,Hayashi Y,Kishi Y,Nakamura H,Akedo H.Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor(HB-EGF).J Cell Physiol 2002;192:351-358[PMID:12124780 DOI:10.1002/jcp.10145]
135 Villar-Garea A,Fraga MF,Espada J,Esteller M.Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.Cancer Res 2003;63:4984-4989[PMID:12941824]
136 Piegeler T,Votta-Velis EG,Liu G,Place AT,Schwartz DE,Beck-Schimmer B,Minshall RD,Borgeat A.Antimetastatic potential of amide-linked local anesthetics:inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade.Anesthesiology 2012;117:548-559[PMID:22846676 DOI:10.1097/ALN.0b013e3182661977]
137 Pastrone I,Viale M,Cafaggi S,MariggiòMA,Parodi A,Esposito M.Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388leukemic cells in vitro and in vivo.Invest New Drugs 1998;16:297 -302[PMID:10426661]
138 Viale M,Pastrone I,Pellecchia C,Vannozzi MO,Cafaggi S,Esposito M.Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.Anticancer Drugs 1998;9:457-463[PMID:9660544]
139 Fleshner M,Bellgrau D,Watkins LR,Laudenslager ML,Maier SF.Stress-induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not to changes in T cell phenotypes.J Neuroimmunol 1995;56:45-52[PMID:7822481]
140 Laudenslager ML,Fleshner M,Hofstadter P,Held PE,Simons L,Maier SF.Suppression of specific antibody production by inescapable shock:stability under varying conditions.Brain Behav Immun 1988;2:92-101[PMID:3148338]
141 Page GG,Blakely WP,Ben-Eliyahu S.Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.Pain 2001;90:191-199[PMID:11166986]
142 Wada H,Seki S,Takahashi T,Kawarabayashi N,Higuchi H,Habu Y,Sugahara S,Kazama T.Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance.Anesthesiology 2007;106:499-506[PMID:17325508]
143 Deegan CA,Murray D,Doran P,Ecimovic P,Moriarty DC,Buggy DJ.Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro.Br J Anaesth 2009;103:685-690[PMID:19776028 DOI:10.1093/bja/aep261]
144 Exadaktylos AK,Buggy DJ,Moriarty DC,Mascha E,Sessler DI.Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?Anesthesiology 2006;105:660 -664[PMID:17006061]
145 Ochroch EA,Fleisher LA.Retrospective analysis:looking backward to point the way forward.Anesthesiology 2006;105:643 -644[PMID:17006057]
146 Haller G,Myles PS.Regional block and cancer recurrence:too early to tell.Anesthesiology 2007;107:354;author reply 354-355[PMID:17667583 DOI:10.1097/01.anes.0000271919.18782.f4]
147 Biki B,Mascha E,Moriarty DC,Fitzpatrick JM,Sessler DI,Buggy DJ.Anesthetic technique for radical prostatectomy surgery affects cancer recurrence:a retrospective analysis.Anesthesiology 2008;109:180-187[PMID:18648226 DOI:10 .1097/ALN.0b013e31817f5b73]
148 Daley MD,Norman PH.Retrospective but not rigorous.Anesthesiology 2009;111:203;author reply 203-204[PMID:19546695 DOI:10.1097/ALN.0b013e3181a85e66]
149 Le Cras AE,Galley HF,Webster NR.Spinal but not general anesthesia increases the ratio of T helper 1 to T helper 2 cell subsets in patients undergoing transurethral resection of the prostate.Anesth Analg 1998;87:1421-1425[PMID:9842841]
150 Wuethrich PY,Thalmann GN,Studer UE,Burkhard FC.Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome:a retrospective study in patients with advanced prostate cancer.PLo S One 2013;8:e72873[PMID:23977366 DOI:10.1371/journal.pone.0072873]
151 Retsky M,Rogers R,Demicheli R,Hrushesky WJ,Gukas I,Vaidya JS,Baum M,Forget P,Dekock M,Pachmann K.NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse:particular relevance to triple negative subgroup.Breast Cancer Res Treat 2012;134:881 -888[PMID:22622810 DOI:10.1007/s10549-012-2094-5]
152 Tsui BC,Rashiq S,Schopflocher D,Murtha A,Broemling S,Pillay J,Finucane BT.Epidural anesthesia and cancer recurrence rates after radical prostatectomy.Can J Anaesth 2010;57:107 -112[PMID:19911247 DOI:10.1007/s12630-009-9214-7]
153 Sessler DI.Regional anesthesia and prostate cancer recurrence.Can J Anaesth 2010;57:99-102[PMID:20041356 DOI:10 .1007/s12630-009-9222-7]
154 Cummings KC,Xu F,Cummings LC,Cooper GS.A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy:a population-based study.Anesthesiology 2012;116:797-806[PMID:22273991 DOI:10.1097/ALN.0b013e31824674f6]
155 Gupta A,Bj?rnsson A,Fredriksson M,Hallb??k O,Eintrei C.Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery:a retrospective analysis of data from 655 patients in central Sweden.Br J Anaesth 2011;107:164-170[PMID:21586443 DOI:10.1093/bja/aer100]
156 Christopherson R,James KE,Tableman M,Marshall P,Johnson FE.Long-term survival after colon cancer surgery:a variation associated with choice of anesthesia.Anesth Analg2008;107:325-332[PMID:18635504 DOI:10.1213/ane.0b013e3181770f55]
157 Gottschalk A,Ford JG,Regelin CC,You J,Mascha EJ,Sessler DI,Durieux ME,Nemergut EC.Association between epidural analgesia and cancer recurrence after colorectal cancer surgery.Anesthesiology 2010;113:27-34[PMID:20508494DOI:10.1097/ALN.0b013e3181de6d0d]
158 Forget P,Leonard D,Kartheuser A,De Kock M.Endpoint selection and unreported analgesic use may render oncologic studies inconclusive.Anesthesiology 2011;114:717;author reply 718[PMID:21343728 DOI:10.1097/ALN.0b013e3182084 b18]
159 Merquiol F,Montelimard AS,Nourissat A,Molliex S,Zufferey PJ.Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery:a retrospective propensity-matched analysis.Reg Anesth Pain Med 2013;38:398-402[PMID:23881179 DOI:10.1097/AAP.0b013e31829cc3fb]
160 Schlagenhauff B,Ellwanger U,Breuninger H,Stroebel W,Rassner G,Garbe C.Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma.Melanoma Res 2000;10:165-169[PMID:10803717]
161 Lacassie HJ,Cartagena J,Bra?es J,Assel M,Echevarría GC.The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population.Anesth Analg 2013;117:653-660[PMID:23868889 DOI:10 .1213/ANE.0b013e3182a07046]
162 Binczak M,Tournay E,Billard V,Rey A,Jayr C.Major abdominal surgery for cancer:does epidural analgesia have a long-term effect on recurrence-free and overall survival?Ann Fr Anesth Reanim 2013;32:e81-e88[PMID:23618609DOI:10.1016/j.annfar.2013.02.027]
163 Chen WK,Miao CH.The effect of anesthetic technique on survival in human cancers:a meta-analysis of retrospective and prospective studies.PLo S One 2013;8:e56540[PMID:23437162 DOI:10.1371/journal.pone.0056540]
164 Oppfeldt A,Carlsson P.The Effect of Paravertebral Block During Surgery on the Recurrence of Breast Cancer.Abstract A4253.American Society of Anesthesiologists.San Francisco,CA,2013.Available from:URL:http://www.asaabstracts.com
165 Weber RS,Jabbour N,Martin RC.Anemia and transfusions in patients undergoing surgery for cancer.Ann Surg Oncol2008;15:34-45[PMID:17943390 DOI:10.1245/s10434-007-9502-9]
166 Blajchman MA.Transfusion-associated immunomodulation and universal white cell reduction:are we putting the cart before the horse?Transfusion 1999;39:665-670[PMID:10413271]
167 Kaplan J,Sarnaik S,Gitlin J,Lusher J.Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.Blood 1984;64:308 -310[PMID:6234037]
168 Brunson ME,Alexander JW.Mechanisms of transfusioninduced immunosuppression.Transfusion 1990;30:651-658[PMID:2205953]
169 Blajchman MA,Bardossy L,Carmen R,Sastry A,Singal DP.Allogeneic blood transfusion-induced enhancement of tumor growth:two animal models showing amelioration by leukodepletion and passive transfer using spleen cells.Blood1993;81:1880-1882[PMID:8461473]
170 Ydy LR,Slhessarenko N,de Aguilar-Nascimento JE.Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection.World J Surg 2007;31:2044-2051[PMID:17671807 DOI:10 .1007/s00268-007-9159-3]
171 Chen G,Zhang FJ,Gong M,Yan M.Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.J Zhejiang Univ Sci B 2007;8:560-565[PMID:17657857 DOI:10.1631/jzus.2007.B0560]
172 Vamvakas EC,Carven JH.Allogeneic blood transfusion,hospital charges,and length of hospitalization:a study of 487 consecutive patients undergoing colorectal cancer resection.Arch Pathol Lab Med 1998;122:145-151[PMID:9499357]
173 Ling FC,Hoelscher AH,Vallb?hmer D,Schmidt D,Picker S,Gathof BS,Bollschweiler E,Schneider PM.Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer.J Gastrointest Surg 2009;13:581 -586 [PMID:19152023 DOI:10.1007/s11605-008-0787-1]
174 Busch OR,Hop WC,Hoynck van Papendrecht MA,Marquet RL,Jeekel J.Blood transfusions and prognosis in colorectal cancer.N Engl J Med 1993;328:1372-1376[PMID:8292113 DOI:10.1056/NEJM199305133281902]
175 Heiss MM,Mempel W,Delanoff C,Jauch KW,Gabka C,Mempel M,Dieterich HJ,Eissner HJ,Schildberg FW.Blood transfusion-modulated tumor recurrence:first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.J Clin Oncol 1994;12:1859-1867[PMID:8083709]
176 Houbiers JG,Brand A,van de Watering LM,Hermans J,Verwey PJ,Bijnen AB,Pahlplatz P,Eeftinck Schattenkerk M,Wobbes T,de Vries JE.Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.Lancet 1994;344:573 -578[PMID:7914960]
177 Beilin B,Martin FC,Shavit Y,Gale RP,Liebeskind JC.Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats.Brain Behav Immun 1989;3:129-137[PMID:2477090]
178 Colacchio TA,Yeager MP,Hildebrandt LW.Perioperative immunomodulation in cancer surgery.Am J Surg 1994;167:174 -179[PMID:8311130]
179 Ben-Eliyahu S.The price of anticancer intervention.Does surgery promote metastasis?Lancet Oncol 2002;3:578-579[PMID:12233735]
180 Grytli HH,Fagerland MW,Foss?SD,Taskén KA,H?heim LL.Use ofβ-blockers is associated with prostate cancerspecific survival in prostate cancer patients on androgen deprivation therapy.Prostate 2013;73:250-260[PMID:22821802DOI:10.1002/pros.22564]
181 Wang HM,Liao ZX,Komaki R,Welsh JW,O’Reilly MS,Chang JY,Zhuang Y,Levy LB,Lu C,Gomez DR.Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.Ann Oncol 2013;24:1312-1319[PMID:23300016 DOI:10.1093/annonc/mds616]
182 Barron TI,Connolly RM,Sharp L,Bennett K,Visvanathan K.Beta blockers and breast cancer mortality:a population-based study.J Clin Oncol 2011;29:2635-2644[PMID:21632503 DOI:10.1200/JCO.2010.33.5422]
183 Melhem-Bertrandt A,Chavez-Macgregor M,Lei X,Brown EN,Lee RT,Meric-Bernstam F,Sood AK,Conzen SD,Hortobagyi GN,Gonzalez-Angulo AM.Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.J Clin Oncol 2011;29:2645-2652[PMID:21632501 DOI:10.1200/JCO.2010.33.4441]
184 Ben-Eliyahu S,Shakhar G,Rosenne E,Levinson Y,Beilin B.Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis:a role for adrenergic mechanisms.Anesthesiology 1999;91:732-740[PMID:10485785]
185 Beilin B,Shavit Y,Razumovsky J,Wolloch Y,Zeidel A,Bessler H.Effects of mild perioperative hypothermia on cellular immune responses.Anesthesiology 1998;89:1133-1140[PMID:9822001]
186 Stefanski V,Ben-Eliyahu S.Social confrontation and tumor metastasis in rats:defeat and beta-adrenergic mechanisms.Physiol Behav 1996;60:277-282[PMID:8804676]
2 Siegel R,Naishadham D,Jemal A.Cancer statistics,2013.CA Cancer J Clin 2013;63:11-30[PMID:23335087 DOI:10.3322/caac.21166]
3 Weinberg R.The Biology of Cancer.In:Garland Science TFGL,editor The Biology of Cancer.New York,2007:587-653
4 Brewster AM,Hortobagyi GN,Broglio KR,Kau SW,SantaMaria CA,Arun B,Buzdar AU,Booser DJ,Valero V,Bondy M,Esteva FJ.Residual risk of breast cancer recurrence 5years after adjuvant therapy.J Natl Cancer Inst 2008;100:1179-1183[PMID:18695137 DOI:10.1093/jnci/djn233]
5 Coffey JC,Wang JH,Smith MJ,Bouchier-Hayes D,Cotter TG,Redmond HP.Excisional surgery for cancer cure:therapy at a cost.Lancet Oncol 2003;4:760-768[PMID:14662433]
6 Ceelen WP,Morris S,Paraskeva P,Pattyn P.Surgical trauma,minimal residual disease and locoregional cancer recurrence.Cancer Treat Res 2007;134:51-69[PMID:17633047]
7 Tai LH,de Souza CT,Bélanger S,Ly L,Alkayyal AA,Zhang J,Rintoul JL,Ananth AA,Lam T,Breitbach CJ,Falls TJ,Kirn DH,Bell JC,Makrigiannis AP,Auer RA.Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells.Cancer Res 2013;73:97-107[PMID:23090117 DOI:10.1158/0008-5472.CAN-12-1993]
8 Fidler IJ.The pathogenesis of cancer metastasis:the‘seed and soil’hypothesis revisited.Nat Rev Cancer 2003;3:453-458[PMID:12778135 DOI:10.1038/nrc1098]
9 Langley RR,Fidler IJ.Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis.Endocr Rev 2007;28:297-321[PMID:17409287 DOI:10.1210/er.2006-0027]
10 Shakhar G,Ben-Eliyahu S.Potential prophylactic measures against postoperative immunosuppression:could they reduce recurrence rates in oncological patients?Ann Surg Oncol 2003;10:972-992[PMID:14527919]
11 Brittenden J,Heys SD,Ross J,Eremin O.Natural killer cells and cancer.Cancer 1996;77:1226-1243[PMID:8608497]
12 Uchida A,Kariya Y,Okamoto N,Sugie K,Fujimoto T,Yagita M.Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients.J Natl Cancer Inst 1990;82:1697-1701[PMID:2231757]
13 Campbell KS,Hasegawa J.Natural killer cell biology:an update and future directions.J Allergy Clin Immunol 2013;132 :536-544[PMID:23906377 DOI:10.1016/j.jaci.2013.07.006]
14 Orange JS.Human natural killer cell deficiencies.Curr Opin Allergy Clin Immunol 2006;6:399-409[PMID:17088643 DOI:10 .1097/ACI.0b013e3280106b65]
15 Liljefors M,Nilsson B,Hjelm Skog AL,Ragnhammar P,Mellstedt H,Fr?din JE.Natural killer(NK)cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.Int J Cancer2003;105:717-723[PMID:12740924 DOI:10.1002/ijc.11139]
16 Kondo E,Koda K,Takiguchi N,Oda K,Seike K,Ishizuka M,Miyazaki M.Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer.Dig Surg 2003;20:445-451[PMID:12900537DOI:10.1159/000072714]
17 Andersen BL,Farrar WB,Golden-Kreutz D,Kutz LA,MacCallum R,Courtney ME,Glaser R.Stress and immune responses after surgical treatment for regional breast cancer.J Natl Cancer Inst 1998;90:30-36[PMID:9428780]
18 Ben-Eliyahu S,Page GG,Yirmiya R,Shakhar G.Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity.Int J Cancer 1999;80:880-888[PMID:10074922]
19 Penn I.The effect of immunosuppression on pre-existing cancers.Transplantation 1993;55:742-747[PMID:8475546]
20 Yeager MP,Rosenkranz KM.Cancer recurrence after surgery:a role for regional anesthesia?Reg Anesth Pain Med2010;35:483-484[PMID:20975458 DOI:10.1097/AAP.0b013e3181fa11a9]
21 Liu SS,Wu CL.The effect of analgesic technique on postoperative patient-reported outcomes including analgesia:a systematic review.Anesth Analg 2007;105:789-808[PMID:17717242 DOI:10.1213/01.ane.0000278089.16848.1e]
22 Tian T,Olson S,Whitacre JM,Harding A.The origins of cancer robustness and evolvability.Integr Biol(Camb)2011;3:17 -30[PMID:20944865 DOI:10.1039/c0ib00046a]
23 Chen DS,Mellman I.Oncology meets immunology:the cancer-immunity cycle.Immunity 2013;39:1-10[PMID:23890059DOI:10.1016/j.immuni.2013.07.012]
24 Boon T,Cerottini JC,Van den Eynde B,van der Bruggen P,Van Pel A.Tumor antigens recognized by T lymphocytes.Annu Rev Immunol 1994;12:337-365[PMID:8011285 DOI:10 .1146/annurev.iy.12.040194.002005]
25 Kaplan DH,Shankaran V,Dighe AS,Stockert E,Aguet M,Old LJ,Schreiber RD.Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.Proc Natl Acad Sci USA 1998;95:7556-7561[PMID:9636188]
26 Shankaran V,Ikeda H,Bruce AT,White JM,Swanson PE,Old LJ,Schreiber RD.IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.Nature 2001;410:1107-1111[PMID:11323675 DOI:10 .1038/35074122]
27 Vivier E,Raulet DH,Moretta A,Caligiuri MA,Zitvogel L,Lanier LL,Yokoyama WM,Ugolini S.Innate or adaptive immunity?The example of natural killer cells.Science 2011;331:44 -49[PMID:21212348 DOI:10.1126/science.1198687]
28 Vivier E,Ugolini S,Blaise D,Chabannon C,Brossay L.Targeting natural killer cells and natural killer T cells in cancer.Nat Rev Immunol 2012;12:239-252[PMID:22437937 DOI:10 .1038/nri3174]
29 Dunn GP,Old LJ,Schreiber RD.The immunobiology of cancer immunosurveillance and immunoediting.Immunity2004;21:137-148[PMID:15308095 DOI:10.1016/j.immuni.2004.07.017]
30 Baum M,Demicheli R,Hrushesky W,Retsky M.Does surgery unfavourably perturb the“natural history”of early breast cancer by accelerating the appearance of distant metastases?Eur J Cancer 2005;41:508-515[PMID:15737554DOI:10.1016/j.ejca.2004.09.031]
31 Ben-Eliyahu S.The promotion of tumor metastasis by surgery and stress:immunological basis and implications for psychoneuroimmunology.Brain Behav Immun 2003;17 Suppl1 :S27-S36[PMID:12615183]
32 Weitz J,Herfarth C.Surgical strategies and minimal residual disease detection.Semin Surg Oncol 2001;20:329-333[PMID:11747275]
33 Oefelein MG,Kaul K,Herz B,Blum MD,Holland JM,Keeler TC,Cook WA,Ignatoff JM.Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy.J Urol 1996;155:238 -242[PMID:7490843]
34 Yamaguchi K,Takagi Y,Aoki S,Futamura M,Saji S.Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.Ann Surg 2000;232:58-65[PMID:10862196]
35 Kim SH,Choe C,Shin YS,Jeon MJ,Choi SJ,Lee J,Bae GY,Cha HJ,Kim J.Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in coculture.Anticancer Res 2013;33:2001-2009[PMID:23645749]
36 Goldfarb Y,Ben-Eliyahu S.Surgery as a risk factor for breast cancer recurrence and metastasis:mediating mechanisms and clinical prophylactic approaches.Breast Dis 2006;26:99 -114[PMID:17473369]
37 Ekblad L,Lindgren G,Persson E,Kjellén E,Wennerberg J.Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors-a central role for STAT3.BMC Cancer2013;13:33[PMID:23351302 DOI:10.1186/1471-2407-13-33]
38 Szarvas T,J?ger T,Laszlo V,Kramer G,Klingler HC,vom Dorp F,Romics I,Ergün S,Rübben H.Circulating angiostatin,b FGF,and Tie2/TEK levels and their prognostic impact in bladder cancer.Urology 2012;80:737.e13-737.e18[PMID:22607948 DOI:10.1016/j.urology.2012.03.023]
39 Fukuda H,Mochizuki S,Abe H,Okano HJ,Hara-Miyauchi C,Okano H,Yamaguchi N,Nakayama M,D’Armiento J,Okada Y.Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.Br J Cancer 2011;105:1615-1624[PMID:22015555DOI:10.1038/bjc.2011.431]
40 Reader J,Holt D,Fulton A.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Cancer Metastasis Rev2011;30:449-463[PMID:22002714 DOI:10.1007/s10555-011-9303-2]
41 Howe LR.Inflammation and breast cancer.Cyclooxygenase/prostaglandin signaling and breast cancer.Breast Cancer Res 2007;9:210[PMID:17640394 DOI:10.1186/bcr1678]
42 Condeelis J,Pollard JW.Macrophages:obligate partners for tumor cell migration,invasion,and metastasis.Cell 2006;124 :263-266[PMID:16439202 DOI:10.1016/j.cell.2006.01.007]
43 Wang L,Chen W,Xie X,He Y,Bai X.Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.Exp Oncol 2008;30:42 -51[PMID:18438340]
44 Sloan EK,Priceman SJ,Cox BF,Yu S,Pimentel MA,Tangkanangnukul V,Arevalo JM,Morizono K,Karanikolas BD,Wu L,Sood AK,Cole SW.The sympathetic nervous system induces a metastatic switch in primary breast cancer.Cancer Res 2010;70:7042-7052[PMID:20823155 DOI:10 .1158/0008-5472.CAN-10-0522]
45 Palm D,Lang K,Niggemann B,Drell TL,Masur K,Zaenker KS,Entschladen F.The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.Int J Cancer 2006;118 :2744-2749[PMID:16381019 DOI:10.1002/ijc.21723]
46 Cole SW,Sood AK.Molecular pathways:beta-adrenergic signaling in cancer.Clin Cancer Res 2012;18:1201-1206[PMID:22186256 DOI:10.1158/1078-0432.CCR-11-0641]
47 Cole SW,Arevalo JM,Takahashi R,Sloan EK,Lutgendorf SK,Sood AK,Sheridan JF,Seeman TE.Computational identification of gene-social environment interaction at the human IL6 locus.Proc Natl Acad Sci USA 2010;107:5681-5686[PMID:20176930 DOI:10.1073/pnas.0911515107]
48 Shahzad MM,Arevalo JM,Armaiz-Pena GN,Lu C,Stone RL,Moreno-Smith M,Nishimura M,Lee JW,Jennings NB,Bottsford-Miller J,Vivas-Mejia P,Lutgendorf SK,LopezBerestein G,Bar-Eli M,Cole SW,Sood AK.Stress effects on FosB-and interleukin-8(IL8)-driven ovarian cancer growth and metastasis.J Biol Chem 2010;285:35462-35470[PMID:20826776 DOI:10.1074/jbc.M110.109579]
49 Sastry KS,Karpova Y,Prokopovich S,Smith AJ,Essau B,Gersappe A,Carson JP,Weber MJ,Register TC,Chen YQ,Penn RB,Kulik G.Epinephrine protects cancer cells from apoptosis via activation of cA MP-dependent protein kinase and BAD phosphorylation.J Biol Chem 2007;282:14094-14100[PMID:17353197 DOI:10.1074/jbc.M611370200]
50 Sood AK,Armaiz-Pena GN,Halder J,Nick AM,Stone RL,Hu W,Carroll AR,Spannuth WA,Deavers MT,Allen JK,Han LY,Kamat AA,Shahzad MM,Mc Intyre BW,DiazMontero CM,Jennings NB,Lin YG,Merritt WM,DeG eest K,Vivas-Mejia PE,Lopez-Berestein G,Schaller MD,Cole SW,Lutgendorf SK.Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.J Clin Invest 2010;120:1515-1523[PMID:20389021 DOI:10.1172/JCI40802]
51 Inbar S,Neeman E,Avraham R,Benish M,Rosenne E,BenEliyahu S.Do stress responses promote leukemia progression?An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.PLo S One 2011;6:e19246[PMID:21559428 DOI:10.1371/journal.pone.0019246]
52 Obeid EI,Conzen SD.The role of adrenergic signaling in breast cancer biology.Cancer Biomark 2013;13:161-169[PMID:23912488 DOI:10.3233/CBM-130347]
53 Landen CN,Lin YG,Armaiz Pena GN,Das PD,Arevalo JM,Kamat AA,Han LY,Jennings NB,Spannuth WA,Thaker PH,Lutgendorf SK,Savary CA,Sanguino AM,Lopez-Berestein G,Cole SW,Sood AK.Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.Cancer Res 2007;67:10389-10396[PMID:17974982DOI:10.1158/0008-5472.CAN-07-0858]
54 Sood AK,Bhatty R,Kamat AA,Landen CN,Han L,Thaker PH,Li Y,Gershenson DM,Lutgendorf S,Cole SW.Stress hormone-mediated invasion of ovarian cancer cells.Clin Cancer Res 2006;12:369-375[PMID:16428474 DOI:10 .1158/1078-0432.CCR-05-1698]
55 Cakir Y,Plummer HK,Tithof PK,Schuller HM.Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines.Int J Oncol 2002;21:153-157[PMID:12063562]
56 Li Q,Liang Z,Nakadai A,Kawada T.Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells,cytotoxic T lymphocytes,natural killer receptors and m RNA transcripts for granzymes and perforin.Stress 2005;8:107-116[PMID:16019602 DOI:10.1080/10253890500140972]
57 Sacerdote P,Manfredi B,Bianchi M,Panerai AE.Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat.Brain Behav Immun 1994;8:251-260[PMID:7865896 DOI:10.1006/brbi.1994.1023]
58 Shavit Y,Martin FC,Yirmiya R,Ben-Eliyahu S,Terman GW,Weiner H,Gale RP,Liebeskind JC.Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity.Brain Behav Immun 1987;1:318-328[PMID:3453207]
59 Bar-Yosef S,Melamed R,Page GG,Shakhar G,Shakhar K,Ben-Eliyahu S.Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats.Anesthesiology 2001;94:1066-1073[PMID:11465599]
60 Lewis JW,Shavit Y,Terman GW,Nelson LR,Gale RP,Liebeskind JC.Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth.Peptides 1983;4 :635-638[PMID:6686324]
61 Sharify A,Mahmoudi M,Izad MH,Hosseini MJ,Sharify M.Effect of acute pain on splenic NK cell activity,lymphocyte proliferation and cytokine production activities.Immunopharmacol Immunotoxicol 2007;29:465-476[PMID:18075858DOI:10.1080/08923970701619877]
62 Page GG.Acute pain and immune impairment.Pain Clin Updates 2005;13:1-4
63 Snyder GL,Greenberg S.Effect of anaesthetic technique and other perioperative factors on cancer recurrence.Br J Anaesth 2010;105:106-115[PMID:20627881 DOI:10.1093/bja/aeq164]
64 Lundy J,Lovett EJ,Hamilton S,Conran P.Halothane,surgery,immunosuppression and artificial pulmonary metastases.Cancer 1978;41:827-830[PMID:638970]
65 Shapiro J,Jersky J,Katzav S,Feldman M,Segal S.Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors.J Clin Invest 1981;68:678-685[PMID:7276167]
66 Urner M,Limbach LK,Herrmann IK,Müller-Edenborn B,Roth-Z’Graggen B,Schlicker A,Reyes L,Booy C,Hasler M,Stark WJ,Beck-Schimmer B.Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury.Am J Respir Cell Mol Biol 2011;45:617-624[PMID:21239603 DOI:10.1165/rcmb.2010-0451OC]
67 Kurosawa S,Kato M.Anesthetics,immune cells,and immune responses.J Anesth 2008;22:263-277[PMID:18685933DOI:10.1007/s00540-008-0626-2]
68 Saad MM,Eom W,Hu G,Kim SJ,Crystal GJ.Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils.Can J Anaesth 2010;57:50-57[PMID:19882198 DOI:10.1007/s12630-009-9205-8]
69 Biao Z,Zhanggang X,Hao J,Changhong M,Jing C.The in vitro effect of desflurane preconditioning on endothelial adhesion molecules and m RNA expression.Anesth Analg2005;100:1007-1013[PMID:15781515 DOI:10.1213/01.ANE.0000146432.39090.D4]
70 Hu G,Vinten-Johansen J,Salem MR,Zhao ZQ,Crystal GJ.Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation:lack of a role for adenosine triphosphate-sensitive potassium channels.Anesth Analg 2002;94:849 -56,table of contents[PMID:11916783]
71 Drenger B,Gozal Y,Ginosar Y,Tochner Z,Chevion M.Halothane modifies oxygen free radical activity on the voltagesensitive calcium channels in canine myocardial membranes.Ann Card Anaesth 1999;2:16-21[PMID:17846486]
72 Benzonana LL,Perry NJ,Watts HR,Yang B,Perry IA,Coombes C,Takata M,Ma D.Isoflurane,a commonly used volatile anesthetic,enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.Anesthesiology 2013;119:593-605[PMID:23774231 DOI:10.1097/ALN.0b013e31829e47fd]
73 Hyv?rinen J,Hassinen IE,Sormunen R,M?ki JM,Kivirikko KI,Koivunen P,Myllyharju J.Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.J Biol Chem2010;285:13646-13657[PMID:20185832 DOI:10.1074/jbc.M109.084855]
74 Bautista L,Castro MJ,López-Barneo J,Castellano A.Hypoxia inducible factor-2alpha stabilization and maxi-K+channel beta1-subunit gene repression by hypoxia in cardiac myocytes:role in preconditioning.Circ Res 2009;104:1364-1372[PMID:19461047 DOI:10.1161/CIRCRESAHA.108.190645]
75 Prabhakar NR,Semenza GL.Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.Physiol Rev 2012;92:967-1003[PMID:22811423 DOI:10.1152/physrev.00030.2011]
76 Ma D,Lim T,Xu J,Tang H,Wan Y,Zhao H,Hossain M,Maxwell PH,Maze M.Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.J Am Soc Nephrol 2009;20:713-720[PMID:19144758DOI:10.1681/ASN.2008070712]
77 Zitta K,Meybohm P,Bein B,Ohnesorge H,Steinfath M,Scholz J,Albrecht M.Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning:findings from a human,in-vitro hypoxia model.Eur J Pharmacol 2010;645:39-46[PMID:20655305 DOI:10.1016/j.ejphar.2010.07.017]
78 Lang XE,Wang X,Jin JH.Mechanisms of cardioprotection by isoflurane against I/R injury.Front Biosci(Landmark Ed)2013;18:387-393[PMID:23276931]
79 Zhang L,Huang H,Cheng J,Liu J,Zhao H,Vizcaychipi MP,Ma D.Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice.Life Sci 2011;88:1102-1107[PMID:21565202 DOI:10.1016/j.lfs.2011.04.004]
80 Müller-Edenborn B,Roth-Z’graggen B,Bartnicka K,Borgeat A,Hoos A,Borsig L,Beck-Schimmer B.Volatile anesthetics reduce invasion of colorectal cancer cells through downregulation of matrix metalloproteinase-9.Anesthesiology 2012;117 :293-301[PMID:22739763 DOI:10.1097/ALN.0b013e3182605df1]
81 Yuki K,Astrof NS,Bracken C,Soriano SG,Shimaoka M.Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1.Anesthesiology 2010;113:600 -609[PMID:20693879 DOI:10.1097/ALN.0b013e3181e89a77]
82 Yuki K,Astrof NS,Bracken C,Yoo R,Silkworth W,Soriano SG,Shimaoka M.The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity.FASEB J 2008;22:4109-4116[PMID:18708587 DOI:10.1096/fj.08-113324]
83 Loop T,Dovi-Akue D,Frick M,Roesslein M,Egger L,Humar M,Hoetzel A,Schmidt R,Borner C,Pahl HL,Geiger KK,Pannen BH.Volatile anesthetics induce caspase-dependent,mitochondria-mediated apoptosis in human T lymphocytes in vitro.Anesthesiology 2005;102:1147-1157[PMID:15915027]
84 Rem J,Brandt MR,Kehlet H.Prevention of postoperative lymphopenia and granulocytosis by epidural analgesia.Lancet 1980;1:283-284[PMID:6101739]
85 Vallejo R,Hord ED,Barna SA,Santiago-Palma J,Ahmed S.Perioperative immunosuppression in cancer patients.J Environ Pathol Toxicol Oncol 2003;22:139-146[PMID:14533877]
86 Woods GM,Griffiths DM.Reversible inhibition of natural killer cell activity by volatile anaesthetic agents in vitro.Br J Anaesth 1986;58:535-539[PMID:3457589]
87 Markovic SN,Knight PR,Murasko DM.Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane.Anesthesiology 1993;78:700 -706[PMID:8466070]
88 T?nnesen E,Brinkl?v MM,Christensen NJ,Olesen AS,Madsen T.Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response.Anesthesiology 1987;67:526 -533[PMID:3499099]
89 Markovic SN,Murasko DM.Anesthesia inhibits interferoninduced natural killer cell cytotoxicity via induction of CD8+suppressor cells.Cell Immunol 1993;151:474-480[PMID:8402951 DOI:10.1006/cimm.1993.1256]
90 Braz MG,Mazoti Má,Giacobino J,Braz LG,Golim Mde A,Ferrasi AC,de Carvalho LR,Braz JR,Salvadori DM.Genotoxicity,cytotoxicity and gene expression in patients undergoing elective surgery under isoflurane anaesthesia.Mutagenesis 2011;26:415-420[PMID:21257718 DOI:10.1093/mutage/geq109]
91 Musak L,Smerhovsky Z,Halasova E,Osina O,Letkova L,Vodickova L,Polakova V,Buchancova J,Hemminki K,Vodicka P.Chromosomal damage among medical staff occupationally exposed to volatile anesthetics,antineoplastic drugs,and formaldehyde.Scand J Work Environ Health 2013;39 :618-630[PMID:23525098 DOI:10.5271/sjweh.3358]
92 Heine J,Leuwer M,Scheinichen D,Arseniev L,Jaeger K,Piepenbrock S.Flow cytometry evaluation of the in vitro influence of four i.v.anaesthetics on respiratory burst of neutrophils.Br J Anaesth 1996;77:387-392[PMID:8949817]
93 Melamed R,Bar-Yosef S,Shakhar G,Shakhar K,Ben-Eliyahu S.Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine,thiopental,and halothane,but not by propofol:mediating mechanisms and prophylactic measures.Anesth Analg 2003;97:1331-1339[PMID:14570648]
94 Salo M,Pirttikangas CO,Pulkki K.Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro.Anaesthesia 1997;52:341-344[PMID:9135186]
95 Chen RM,Wu CH,Chang HC,Wu GJ,Lin YL,Sheu JR,Chen TL.Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis.Anesthesiology 2003;98:1178-1185[PMID:12717140]
96 Heller A,Heller S,Blecken S,Urbaschek R,Koch T.Effects of intravenous anesthetics on bacterial elimination in human blood in vitro.Acta Anaesthesiol Scand 1998;42:518-526[PMID:9605366]
97 Wu GJ,Tai YT,Chen TL,Lin LL,Ueng YF,Chen RM.Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity,thus reducing cellular ATP biosynthesis and migration of macrophages.Ann N Y Acad Sci 2005;1042:168-176[PMID:15965060 DOI:10.1196/annals.1338.019]
98 Hardwick M,Fertikh D,Culty M,Li H,Vidic B,Papadopoulos V.Peripheral-type benzodiazepine receptor(PBR)in human breast cancer:correlation of breast cancer cell aggressive phenotype with PBR expression,nuclear localization,and PBR-mediated cell proliferation and nuclear transport of cholesterol.Cancer Res 1999;59:831-842[PMID:10029072]
99 Garib V,Niggemann B,Z?nker KS,Brandt L,Kubens BS.Influence of non-volatile anesthetics on the migration behavior of the human breast cancer cell line MDA-MB-468.Acta Anaesthesiol Scand 2002;46:836-844[PMID:12139540]
100 Katzav S,Shapiro J,Segal S,Feldman M.General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity.Isr J Med Sci 1986;22:339-345[PMID:3744781]
101 Bentley MW,Stas JM,Johnson JM,Viet BC,Garrett N.Effects of preincisional ketamine treatment on natural killer cell activity and postoperative pain management after oral maxillofacial surgery.AANA J 2005;73:427-436[PMID:16355944]
102 Singleton PA,Moreno-Vinasco L,Sammani S,Wanderling SL,Moss J,Garcia JG.Attenuation of vascular permeability by methylnaltrexone:role of m OP-R and S1P3 transactivation.Am J Respir Cell Mol Biol 2007;37:222-231[PMID:17395891 DOI:10.1165/rcmb.2006-0327OC]
103 Singleton PA,Moss J.Effect of perioperative opioids on cancer recurrence:a hypothesis.Future Oncol 2010;6:1237-1242[PMID:20799870 DOI:10.2217/fon.10.99]
104 Carr DJ,Rogers TJ,Weber RJ.The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis.Proc Soc Exp Biol Med 1996;213:248-257[PMID:8985308]
105 Flores LR,Dretchen KL,Bayer BM.Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration.Eur J Pharmacol 1996;318:437 -446[PMID:9016936]
106 Freier DO,Fuchs BA.A mechanism of action for morphineinduced immunosuppression:corticosterone mediates morphine-induced suppression of natural killer cell activity.J Pharmacol Exp Ther 1994;270:1127-1133[PMID:7932161]
107 Bryant HU,Bernton EW,Kenner JR,Holaday JW.Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment.Endocrinology 1991;128:3253-3258[PMID:2036988]
108 Mellon RD,Bayer BM.Evidence for central opioid receptors in the immunomodulatory effects of morphine:review of potential mechanism(s)of action.J Neuroimmunol 1998;83:19 -28[PMID:9610669]
109 Shavit Y,Ben-Eliyahu S,Zeidel A,Beilin B.Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats.Dose and timing study.Neuroimmunomodulation2004;11:255-260[PMID:15249732 DOI:10.1159/000078444]
110 Li W,Tang HZ,Jiang YB,Xu MX.[Influence of different doses of fentanyl on T-lymphocyte subpopulations and natural killer cells of patients with esophageal tumor during preoperation and postoperation].Aizheng 2003;22:634-636[PMID:12948416]
111 Jaeger K,Scheinichen D,Heine J,AndréM,Bund M,Piepenbrock S,Leuwer M.Remifentanil,fentanyl,and alfentanil have no influence on the respiratory burst of human neutrophils in vitro.Acta Anaesthesiol Scand 1998;42:1110-1113[PMID:9809098]
112 Gaspani L,Bianchi M,Limiroli E,Panerai AE,Sacerdote P.The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats.J Neuroimmunol 2002;129:18-24[PMID:12161016]
113 Liu YM,Zhu SM,Wang KR,Feng ZY,Chen QL.Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain.Zhejiang Daxue Kexue Zazhi B 2008;9:895-902[PMID:18988309 DOI:10.1631/jzus.B0820039]
114 Sacerdote P,Bianchi M,Gaspani L,Manfredi B,Maucione A,Terno G,Ammatuna M,Panerai AE.The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients.Anesth Analg 2000;90:1411-1414[PMID:10825330]
115 McL aughlin PJ,Zagon IS.The opioid growth factor-opioid growth factor receptor axis:homeostatic regulator of cell proliferation and its implications for health and disease.Biochem Pharmacol 2012;84:746-755[PMID:22687282 DOI:10 .1016/j.bcp.2012.05.018]
116 Spirkoski J,Melo FR,Grujic M,Calounova G,Lundequist A,Wernersson S,Pejler G.Mast cell apoptosis induced by siramesine,a sigma-2 receptor agonist.Biochem Pharmacol 2012;84:1671-1680[PMID:23058984 DOI:10.1016/j.bcp.2012.09.028]
117 Stefano GB,Kream RM,Mantione KJ,Sheehan M,Cadet P,Zhu W,Bilfinger TV,Esch T.Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression:implications for cancer biology.Semin Cancer Biol2008;18:199-210[PMID:18203618 DOI:10.1016/j.semcancer.2007.12.003]
118 Cadet P,Rasmussen M,Zhu W,Tonnesen E,Mantione KJ,Stefano GB.Endogenous morphinergic signaling and tumor growth.Front Biosci 2004;9:3176-3186[PMID:15353348]
119 Tegeder I,Gr?sch S,Schmidtko A,H?ussler A,Schmidt H,Niederberger E,Scholich K,Geisslinger G.G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells:involvement of p53 phosphorylation.Cancer Res 2003;63:1846-1852[PMID:12702572]
120 Tsujikawa H,Shoda T,Mizota T,Fukuda K.Morphine induces DNA damage and P53 activation in CD3+T cells.Biochim Biophys Acta 2009;1790:793-799[PMID:19397953 DOI:10 .1016/j.bbagen.2009.04.011]
121 Yin D,Woodruff M,Zhang Y,Whaley S,Miao J,Ferslew K,Zhao J,Stuart C.Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappa B pathways.J Neuroimmunol 2006;174 :101-107[PMID:16529824 DOI:10.1016/j.jneuroim.2006.02.001]
122 Qin Y,Chen J,Li L,Liao CJ,Liang YB,Guan EJ,Xie YB.Exogenous morphine inhibits human gastric cancer MGC803 cell growth by cell cycle arrest and apoptosis induction.Asian Pac J Cancer Prev 2012;13:1377-1382[PMID:22799335]
123 Gach K,Wyrebska A,Fichna J,Janecka A.The role of morphine in regulation of cancer cell growth.Naunyn Schmiedebergs Arch Pharmacol 2011;384:221-230[PMID:21800094DOI:10.1007/s00210-011-0672-4]
124 Chen YL,Law PY,Loh HH.The other side of the opioid story:modulation of cell growth and survival signaling.Curr Med Chem 2008;15:772-778[PMID:18393846]
125 Yeager MP,Colacchio TA.Effect of morphine on growth of metastatic colon cancer in vivo.Arch Surg 1991;126:454-456[PMID:2009060]
126 Page GG,Ben-Eliyahu S,Yirmiya R,Liebeskind JC.Morphine attenuates surgery-induced enhancement of metastatic colonization in rats.Pain 1993;54:21-28[PMID:8378099]
127 Page GG,Ben-Eliyahu S,Liebeskind JC.The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine.Brain Behav Immun 1994;8:241-250[PMID:7865895]
128 Tarhini AA,Cherian J,Moschos SJ,Tawbi HA,Shuai Y,Gooding WE,Sander C,Kirkwood JM.Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.J Clin Oncol 2012;30:322-328[PMID:22184371 DOI:10.1200/JCO.2011.37.5394]
129 Van Gool AR,Van Ojik HH,Kruit WH,Mulder PG,Fekkes D,Bannink M,ScharpéS,Stoter G,Eggermont AM,Maes M,Verkerk R.Serum activity of prolyl endopeptidase,but not of dipeptidyl peptidase IV,is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients.J Interferon Cytokine Res 2004;24:411-415[PMID:15296652 DOI:10.1089/1079990041535629]
130 Van Gool AR,Verkerk R,Fekkes D,Sleijfer S,Bannink M,Kruit WH,van der Holt B,ScharpéS,Eggermont AM,Stoter G,Hengeveld MW.Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-alpha in patients with renal cell carcinoma.J Interferon Cytokine Res 2008;28:283-286[PMID:18547158 DOI:10 .1089/jir.2007.0058]
131 Hollmann MW,Gross A,Jelacin N,Durieux ME.Local anesthetic effects on priming and activation of human neutrophils.Anesthesiology 2001;95:113-122[PMID:11465548]
132 Johnson SM,Saint John BE,Dine AP.Local anesthetics as antimicrobial agents:a review.Surg Infect(Larchmt)2008;9:205 -213[PMID:18426354 DOI:10.1089/sur.2007.036]
133 Di Padova M,Barbieri R,Fanciulli M,Arcuri E,Floridi A.Effect of local anesthetic ropivacaine on the energy metabolism of Ehrlich ascites tumor cells.Oncol Res 1998;10:491-498[PMID:10338152]
134 Mammoto T,Higashiyama S,Mukai M,Mammoto A,Ayaki M,Mashimo T,Hayashi Y,Kishi Y,Nakamura H,Akedo H.Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor(HB-EGF).J Cell Physiol 2002;192:351-358[PMID:12124780 DOI:10.1002/jcp.10145]
135 Villar-Garea A,Fraga MF,Espada J,Esteller M.Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.Cancer Res 2003;63:4984-4989[PMID:12941824]
136 Piegeler T,Votta-Velis EG,Liu G,Place AT,Schwartz DE,Beck-Schimmer B,Minshall RD,Borgeat A.Antimetastatic potential of amide-linked local anesthetics:inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade.Anesthesiology 2012;117:548-559[PMID:22846676 DOI:10.1097/ALN.0b013e3182661977]
137 Pastrone I,Viale M,Cafaggi S,MariggiòMA,Parodi A,Esposito M.Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388leukemic cells in vitro and in vivo.Invest New Drugs 1998;16:297 -302[PMID:10426661]
138 Viale M,Pastrone I,Pellecchia C,Vannozzi MO,Cafaggi S,Esposito M.Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.Anticancer Drugs 1998;9:457-463[PMID:9660544]
139 Fleshner M,Bellgrau D,Watkins LR,Laudenslager ML,Maier SF.Stress-induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not to changes in T cell phenotypes.J Neuroimmunol 1995;56:45-52[PMID:7822481]
140 Laudenslager ML,Fleshner M,Hofstadter P,Held PE,Simons L,Maier SF.Suppression of specific antibody production by inescapable shock:stability under varying conditions.Brain Behav Immun 1988;2:92-101[PMID:3148338]
141 Page GG,Blakely WP,Ben-Eliyahu S.Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.Pain 2001;90:191-199[PMID:11166986]
142 Wada H,Seki S,Takahashi T,Kawarabayashi N,Higuchi H,Habu Y,Sugahara S,Kazama T.Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance.Anesthesiology 2007;106:499-506[PMID:17325508]
143 Deegan CA,Murray D,Doran P,Ecimovic P,Moriarty DC,Buggy DJ.Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro.Br J Anaesth 2009;103:685-690[PMID:19776028 DOI:10.1093/bja/aep261]
144 Exadaktylos AK,Buggy DJ,Moriarty DC,Mascha E,Sessler DI.Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?Anesthesiology 2006;105:660 -664[PMID:17006061]
145 Ochroch EA,Fleisher LA.Retrospective analysis:looking backward to point the way forward.Anesthesiology 2006;105:643 -644[PMID:17006057]
146 Haller G,Myles PS.Regional block and cancer recurrence:too early to tell.Anesthesiology 2007;107:354;author reply 354-355[PMID:17667583 DOI:10.1097/01.anes.0000271919.18782.f4]
147 Biki B,Mascha E,Moriarty DC,Fitzpatrick JM,Sessler DI,Buggy DJ.Anesthetic technique for radical prostatectomy surgery affects cancer recurrence:a retrospective analysis.Anesthesiology 2008;109:180-187[PMID:18648226 DOI:10 .1097/ALN.0b013e31817f5b73]
148 Daley MD,Norman PH.Retrospective but not rigorous.Anesthesiology 2009;111:203;author reply 203-204[PMID:19546695 DOI:10.1097/ALN.0b013e3181a85e66]
149 Le Cras AE,Galley HF,Webster NR.Spinal but not general anesthesia increases the ratio of T helper 1 to T helper 2 cell subsets in patients undergoing transurethral resection of the prostate.Anesth Analg 1998;87:1421-1425[PMID:9842841]
150 Wuethrich PY,Thalmann GN,Studer UE,Burkhard FC.Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome:a retrospective study in patients with advanced prostate cancer.PLo S One 2013;8:e72873[PMID:23977366 DOI:10.1371/journal.pone.0072873]
151 Retsky M,Rogers R,Demicheli R,Hrushesky WJ,Gukas I,Vaidya JS,Baum M,Forget P,Dekock M,Pachmann K.NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse:particular relevance to triple negative subgroup.Breast Cancer Res Treat 2012;134:881 -888[PMID:22622810 DOI:10.1007/s10549-012-2094-5]
152 Tsui BC,Rashiq S,Schopflocher D,Murtha A,Broemling S,Pillay J,Finucane BT.Epidural anesthesia and cancer recurrence rates after radical prostatectomy.Can J Anaesth 2010;57:107 -112[PMID:19911247 DOI:10.1007/s12630-009-9214-7]
153 Sessler DI.Regional anesthesia and prostate cancer recurrence.Can J Anaesth 2010;57:99-102[PMID:20041356 DOI:10 .1007/s12630-009-9222-7]
154 Cummings KC,Xu F,Cummings LC,Cooper GS.A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy:a population-based study.Anesthesiology 2012;116:797-806[PMID:22273991 DOI:10.1097/ALN.0b013e31824674f6]
155 Gupta A,Bj?rnsson A,Fredriksson M,Hallb??k O,Eintrei C.Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery:a retrospective analysis of data from 655 patients in central Sweden.Br J Anaesth 2011;107:164-170[PMID:21586443 DOI:10.1093/bja/aer100]
156 Christopherson R,James KE,Tableman M,Marshall P,Johnson FE.Long-term survival after colon cancer surgery:a variation associated with choice of anesthesia.Anesth Analg2008;107:325-332[PMID:18635504 DOI:10.1213/ane.0b013e3181770f55]
157 Gottschalk A,Ford JG,Regelin CC,You J,Mascha EJ,Sessler DI,Durieux ME,Nemergut EC.Association between epidural analgesia and cancer recurrence after colorectal cancer surgery.Anesthesiology 2010;113:27-34[PMID:20508494DOI:10.1097/ALN.0b013e3181de6d0d]
158 Forget P,Leonard D,Kartheuser A,De Kock M.Endpoint selection and unreported analgesic use may render oncologic studies inconclusive.Anesthesiology 2011;114:717;author reply 718[PMID:21343728 DOI:10.1097/ALN.0b013e3182084 b18]
159 Merquiol F,Montelimard AS,Nourissat A,Molliex S,Zufferey PJ.Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery:a retrospective propensity-matched analysis.Reg Anesth Pain Med 2013;38:398-402[PMID:23881179 DOI:10.1097/AAP.0b013e31829cc3fb]
160 Schlagenhauff B,Ellwanger U,Breuninger H,Stroebel W,Rassner G,Garbe C.Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma.Melanoma Res 2000;10:165-169[PMID:10803717]
161 Lacassie HJ,Cartagena J,Bra?es J,Assel M,Echevarría GC.The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population.Anesth Analg 2013;117:653-660[PMID:23868889 DOI:10 .1213/ANE.0b013e3182a07046]
162 Binczak M,Tournay E,Billard V,Rey A,Jayr C.Major abdominal surgery for cancer:does epidural analgesia have a long-term effect on recurrence-free and overall survival?Ann Fr Anesth Reanim 2013;32:e81-e88[PMID:23618609DOI:10.1016/j.annfar.2013.02.027]
163 Chen WK,Miao CH.The effect of anesthetic technique on survival in human cancers:a meta-analysis of retrospective and prospective studies.PLo S One 2013;8:e56540[PMID:23437162 DOI:10.1371/journal.pone.0056540]
164 Oppfeldt A,Carlsson P.The Effect of Paravertebral Block During Surgery on the Recurrence of Breast Cancer.Abstract A4253.American Society of Anesthesiologists.San Francisco,CA,2013.Available from:URL:http://www.asaabstracts.com
165 Weber RS,Jabbour N,Martin RC.Anemia and transfusions in patients undergoing surgery for cancer.Ann Surg Oncol2008;15:34-45[PMID:17943390 DOI:10.1245/s10434-007-9502-9]
166 Blajchman MA.Transfusion-associated immunomodulation and universal white cell reduction:are we putting the cart before the horse?Transfusion 1999;39:665-670[PMID:10413271]
167 Kaplan J,Sarnaik S,Gitlin J,Lusher J.Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.Blood 1984;64:308 -310[PMID:6234037]
168 Brunson ME,Alexander JW.Mechanisms of transfusioninduced immunosuppression.Transfusion 1990;30:651-658[PMID:2205953]
169 Blajchman MA,Bardossy L,Carmen R,Sastry A,Singal DP.Allogeneic blood transfusion-induced enhancement of tumor growth:two animal models showing amelioration by leukodepletion and passive transfer using spleen cells.Blood1993;81:1880-1882[PMID:8461473]
170 Ydy LR,Slhessarenko N,de Aguilar-Nascimento JE.Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection.World J Surg 2007;31:2044-2051[PMID:17671807 DOI:10 .1007/s00268-007-9159-3]
171 Chen G,Zhang FJ,Gong M,Yan M.Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.J Zhejiang Univ Sci B 2007;8:560-565[PMID:17657857 DOI:10.1631/jzus.2007.B0560]
172 Vamvakas EC,Carven JH.Allogeneic blood transfusion,hospital charges,and length of hospitalization:a study of 487 consecutive patients undergoing colorectal cancer resection.Arch Pathol Lab Med 1998;122:145-151[PMID:9499357]
173 Ling FC,Hoelscher AH,Vallb?hmer D,Schmidt D,Picker S,Gathof BS,Bollschweiler E,Schneider PM.Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer.J Gastrointest Surg 2009;13:581 -586 [PMID:19152023 DOI:10.1007/s11605-008-0787-1]
174 Busch OR,Hop WC,Hoynck van Papendrecht MA,Marquet RL,Jeekel J.Blood transfusions and prognosis in colorectal cancer.N Engl J Med 1993;328:1372-1376[PMID:8292113 DOI:10.1056/NEJM199305133281902]
175 Heiss MM,Mempel W,Delanoff C,Jauch KW,Gabka C,Mempel M,Dieterich HJ,Eissner HJ,Schildberg FW.Blood transfusion-modulated tumor recurrence:first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.J Clin Oncol 1994;12:1859-1867[PMID:8083709]
176 Houbiers JG,Brand A,van de Watering LM,Hermans J,Verwey PJ,Bijnen AB,Pahlplatz P,Eeftinck Schattenkerk M,Wobbes T,de Vries JE.Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.Lancet 1994;344:573 -578[PMID:7914960]
177 Beilin B,Martin FC,Shavit Y,Gale RP,Liebeskind JC.Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats.Brain Behav Immun 1989;3:129-137[PMID:2477090]
178 Colacchio TA,Yeager MP,Hildebrandt LW.Perioperative immunomodulation in cancer surgery.Am J Surg 1994;167:174 -179[PMID:8311130]
179 Ben-Eliyahu S.The price of anticancer intervention.Does surgery promote metastasis?Lancet Oncol 2002;3:578-579[PMID:12233735]
180 Grytli HH,Fagerland MW,Foss?SD,Taskén KA,H?heim LL.Use ofβ-blockers is associated with prostate cancerspecific survival in prostate cancer patients on androgen deprivation therapy.Prostate 2013;73:250-260[PMID:22821802DOI:10.1002/pros.22564]
181 Wang HM,Liao ZX,Komaki R,Welsh JW,O’Reilly MS,Chang JY,Zhuang Y,Levy LB,Lu C,Gomez DR.Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.Ann Oncol 2013;24:1312-1319[PMID:23300016 DOI:10.1093/annonc/mds616]
182 Barron TI,Connolly RM,Sharp L,Bennett K,Visvanathan K.Beta blockers and breast cancer mortality:a population-based study.J Clin Oncol 2011;29:2635-2644[PMID:21632503 DOI:10.1200/JCO.2010.33.5422]
183 Melhem-Bertrandt A,Chavez-Macgregor M,Lei X,Brown EN,Lee RT,Meric-Bernstam F,Sood AK,Conzen SD,Hortobagyi GN,Gonzalez-Angulo AM.Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.J Clin Oncol 2011;29:2645-2652[PMID:21632501 DOI:10.1200/JCO.2010.33.4441]
184 Ben-Eliyahu S,Shakhar G,Rosenne E,Levinson Y,Beilin B.Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis:a role for adrenergic mechanisms.Anesthesiology 1999;91:732-740[PMID:10485785]
185 Beilin B,Shavit Y,Razumovsky J,Wolloch Y,Zeidel A,Bessler H.Effects of mild perioperative hypothermia on cellular immune responses.Anesthesiology 1998;89:1133-1140[PMID:9822001]
186 Stefanski V,Ben-Eliyahu S.Social confrontation and tumor metastasis in rats:defeat and beta-adrenergic mechanisms.Physiol Behav 1996;60:277-282[PMID:8804676]